Severe Adverse Drug Reactions to Quetiapine in Two Patients Carrying CYP2D6*4 Variants: A Case Report

We report two cases of patients who developed severe adverse drug reactions including persistent movement disorders, nausea, and vertigo during treatment with quetiapine at maximum daily doses ranging between 300 and 400 mg. The extensive hepatic metabolism of quetiapine is mainly attributed to cyto...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Int J Mol Sci
Main Authors: Stäuble, Céline K., Lampert, Markus L., Mikoteit, Thorsten, Hatzinger, Martin, Hersberger, Kurt E., Meyer zu Schwabedissen, Henriette E.
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2021
Teme:
Case Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8233787/
https://ncbi.nlm.nih.gov/pubmed/34204223
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22126480
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki